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ABSTRACT
Fetal growth restriction (FGR) is often the result of placental insufficiency and is 
characterized by insufficient transplacental transport of nutrients and oxygen. The 
main underlying entities of placental insufficiency, the pathophysiologic mechanism, 
can broadly be divided into impairments in blood flow and exchange capacity over 
the syncytiovascular membranes of the fetal placenta villi. Fetal growth restriction is 
not synonymous with small for gestational age and techniques to distinguish between 
both are needed. Placental insufficiency has significant associations with adverse 
pregnancy outcomes (perinatal mortality and morbidity). Even in apparently healthy 
survivors, altered fetal programming may lead to long-term neurodevelopmental 
and metabolic effects. Although the concept of fetal growth restriction is well 
appreciated in contemporary obstetrics, the appropriate detection of FGR remains 
an issue in clinical practice. Several approaches have aimed to improve detection, 
e.g., uniform definition of FGR, use of Doppler ultrasound profiles and use of growth 
trajectories by ultrasound fetal biometry. However, the role of placental morphometry 
(placental dimensions/shape and weight) deserves further exploration. This review 
article covers the clinical relevance of placental morphometry during pregnancy 
and at birth to help recognize fetuses who are growth restricted. The assessment 
has wide intra- and interindividual variability with various consequences. Previous 
studies have shown that a small placental surface area and low placental weight are 
associated with a slower growth of the fetus. Parameters such as placental surface 
area, placental volume and placental weight in relation to birth weight can help 
to identify FGR. In the future, a model including sophisticated antenatal placental 
morphometry may prove to be a clinically useful method for screening or diagnosing 
growth restricted fetuses, in order to provide optimal monitoring.
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BACKGROUND
The diagnosis of fetal growth restriction (FGR) has for long mainly be based on birth 
weight below a reference cut-off, most commonly the 10th percentile (p10) 1. Birth 
weight (BW) or estimated fetal weight (EFW) below p10 indicates that the BW or 
EFW is within the lowest ten percent of BW compared to the reference population. 
This is in essence not FGR but small for gestational age (SGA). There are some 
important diagnostic issues with this misnomer. First, about 75% of fetuses who 
are SGA (and therefore many who are FGR) remain unrecognized until they are 
born and the diagnosis is made on the baby scale, postnatally 1,2, meaning some 
are severely compromised, exposed to potential long term sequelae, or even 
stillborn. Second, fetuses who are too small according to the intra uterine reference 
chart may be physiologically small and appropriate grown according to their 
individual growth potential (based upon their genetic and epigenetic inheritance at 
conception), and therefore not at risk from diseases related to FGR, but are exposed 
to unnecessary investigations for FGR. Third, many cases of growth restriction remain 
unacknowledged, when a baby or fetus is too small according to its individual growth 
potential, but not necessarily too small in the population based reference chart. 
Thus FGR overlaps with, but is not synonymous to, SGA 3 (‘SGA-FGR confusion’), as 
two overlapping distribution curves. It is self-evident that the incidence of growth 
restricted fetuses increases as EFW or BW percentiles decreases 4. Yet, there is not 
a single cut-off above which all babies have grown appropriately, or below which 
none have grown appropriately for their individual biological growth potential. If SGA 
is used as the proxy for FGR in clinical practice, healthy SGA fetuses and neonates 
without FGR are prone to unnecessary monitoring intervention strategies and FGR 
fetuses and neonates who are FGR but not SGA remain unrecognized (‘masked’ FGR). 
Furthermore, if SGA is used as proxy for FGR in research, the study population is 
diluted by healthy small fetuses and newborns, hampering adequate association 
studies. It is estimated that in the SGA group, 60% were growth restricted, and 40% 
were constitutionally small (Figure 1) 5. In this study, “constitutionally small” was 
defined as fetuses with moderately low BW (>3rd percentile) and normal placental 
function on both the fetal (normal cerebroplacental ratio) and maternal (normal 
uterine Doppler) sides. Severe growth restriction or evidence of placental dysfunction 
was defined as “growth restricted” 5.
This study implies the relevance of appropriate, possibly easy to obtain, and cheap 
diagnostic tools to detect only those fetuses who are growth restricted because 
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these are the fetuses who have an increased risk of adverse short- and long-term 
outcomes when not delivered in time 6–8.
The causes of FGR can be divided into pre-utero-placental (e.g. maternal anemia, 
hypoxia, malnourishment), utero-placental (e.g. poor implantation, pre-eclampsia) 
and fetal conditions (e.g. fetal infection, some maldevelopments), and conditions 
like twin to twin transfusion. The utero-placental group appears the largest 9, and 
the main focus to date has been on histopathological changes such as maternal 
malperfusion, villitis and more recently terminal villous hypoplasia. However, recently 
more focus has been made on examining the role of the gross examination of the 
placenta, with weight, shape, cord insertion. With better identification of the factors 
that are associated or causative for FGR, the baby who may or may not be small 
can still be identified as at risk for sequelae of FGR, based upon the severity of the 
changes. The issue is complex as the relationship is not straightforward, and several 
opposing forces are occurring. The placenta is not inert and does not grow purely 
as its genes dictate, but it appears to respond to the demands of the fetus and also 
the supply from the mother, appearing to adapt and compensate. It does this on a 
local level controlling blood flow through the stem villi with the arterial muscle, and 
globally, causing the increased placental resistance that in turn is identified by the 
Doppler studies. Furthermore, the fetus does the same with its redistribution of the 
blood, to the brain, at the cost of the liver glycogen and fatty tissue stores. There 
may also be a tradeoff on how much of the overall nutrient going to the conceptus is 
used for the placenta (to maximize uptake) or to the fetus, but usually the birth weight 
to placenta weight-ratio (BWPW-ratio) increases in conditions with FGR. In addition, 
there are also well established differences between male and female fetuses.
Ideally for every fetus, all the relevant factors are assessed to give a rational approach 
to answer the question whether the fetus has reached its full growth percentile, based 
on the assessment of significant evidence of less than optimal maternal factors, 
uteroplacental factors including gross and histopathological placental examination, 
and fetal factors.
In this literature review we focus on the gross examination of the placenta and we 
aim to give an overview on the possible use of placental morphometry in recognizing 
fetuses and neonates with growth restriction, independent of their weight.
Diagnosis of fetal growth restriction
The most common pathophysiologic mechanism of FGR is placental insufficiency, 
with multiple underlying maternal, fetal and placental causes, resulting in insufficient 
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nutrition and oxygen supply to the fetus 9. As mentioned above, the diagnostic process 
is complicated by the “SGA-FGR confusion”. Placental insufficiency, placing fetuses at 
increased risk of hypoxia and malnourishment related morbidity, as well as stillbirth, 
is not restricted to those fetuses who are growth restricted and small, but also to 
those within normal weight ranges. The “masked” FGR fetuses in the subgroup of 
appropriate for gestational age (AGA) or even large for gestational age (LGA) fetuses, 
also experience placental insufficiency (assessed by umbilical artery pulsatility index 
(PI), middle cerebral artery PI, cerebroplacental ratio) 10. They show a slower growth 
trajectory during pregnancy, and are prone to the same risks. In addition, these fetuses 
have a further doubling of stillbirth risk compared to those fetuses with detected 
FGR, because no interventions to modify that risk are installed 11,12. Clinically, these 
fetuses can only be recognized with sequential ultrasound measurements that show 
a decline in weight centiles, which is not routinely applied in general midwifery and 
obstetric practice. FGR, particularly early onset, is associated with histopathological 
changes through later onset may be histologically unremarkable 13.
The major challenge of FGR is the diagnostic standard. In 2016 an international Delphi 
procedure among 56 experts on FGR was established to come to a consensus 
definition for both early (<32 weeks of gestation) and late FGR (≥32 weeks of gestation) 
14. In this definition not only size parameters of the fetus but also parameters of 
placental function, either alone or in combination, are included and have been used 
widely since publication. The clinical applicability of these definitions in predicting 
adverse outcomes is yet to be assessed.
The role of placental size in fetal growth
Normal growth of the fetus is mainly dependent on normal placental function, with 
normal placental morphometry (size and shape) and normal structure. Impairments in 
placental development, including reduced placental size, or altered placental nutrient 
transport capability contribute to placental dysfunction 15. Placental dysfunction 
attributable to structural fetal or genetic fetal defects share similar pathophysiologic 
pathways but are characterized by a different set of pathophysiologic features and 
are not included in this review. These factors contributing to placental dysfunction, 
as well as changes in the placental transport system, result in FGR.
To illustrate, it is known that transporter activity of system A amino acid uptake is 
reduced in placentas from FGR fetuses with abnormal umbilical artery Dopplers, 
and that it is also related to the severity of FGR 16. The capability of the placenta to 
maintain sufficient nutrient supply is commonly described as “placental efficiency” 
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and is described to be reflected by BWPW-ratio 17. The increased risk of stillbirth may 
reflect less “placental reserve” with a high BWPW-ratio, where the fetus is running 
higher risk of stillbirth and yet maximizing its albeit constrained weight and growth. In 
animal studies, positive correlations were found between BWPW-ratio and placental 
uptake of nutrient transport system A amino acid uptake, indicating that nutrient 
transfer per gram placenta must have increased compared to low or normal BWPW-
ratio 18. However, in human studies these effects are less conclusive regarding the 
system A transporter. A low BWPW-ratio describes fetuses with a relatively large 
placenta (higher placental weight) compared to the birth weight, whereby the nutrient 
transfer is reduced per gram placenta.
Antenatal measurement of placental function
Prenatal screening for FGR in general obstetrical populations involves identifying 
risk factors for impaired fetal growth. When the fetus is identified to be at risk for 
FGR, sequential assessment of fetal size, either by anatomical reference points or by 
sequential ultrasound is executed. Actual fetal size reflects past placental function 
until that point in time, whereby “real time” placental function can be assessed in 
vivo by measurement of vascular resistance Doppler flows in the mother (uterine 
artery) or in the fetus (umbilical artery and middle cerebral artery) 19. Doppler flow 
measurements enable the non-invasive detection of signs of placental insufficiency 
and fetal hemodynamic changes that occur during oxygen deprivation. During 
the course of normal, healthy, pregnancies, umbilical artery resistance decreases 
gradually throughout gestation, and increases with placental insufficiency 20. Ghosh 
et al. suggested in their study on pregnancies complicated by suspected FGR 
fetuses that abnormal Doppler patterns of the uterine arteries could identify a fetus 
at increased risk, even in the presence of normal umbilical artery Doppler flow 21. 
Regarding fetal biometry, abdominal circumference is smaller in FGR fetuses due to 
depletion of abdominal adipose tissue as well as smaller liver size, because of reduced 
glycogen storage. As solitary parameter in the detection of FGR, measurement of the 
abdominal circumference is the most sensitive 22. In case of placental insufficiency 
and decreased oxygen and nutrients supply, the fetus redistributes the blood to the 
brain, at the costs of the liver glycogen and fatty issue stores, resulting in normal fetal 
brain growth and decline of growth of the abdominal circumference.
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Measurement of serum biomarkers
Biochemical biomarkers that reflect placental function and adverse pregnancy 
outcomes, including FGR, are increasingly subject of research. A systematic 
review conducted in 2013, assessed 53 studies investigating biomarkers that could 
potentially have a role in screening for FGR. They concluded that none of the 37 
different biomarkers were sufficiently accurate to function as a predictor of FGR 23. 
However, different definitions of FGR were used in the evaluated studies in which 
the vast majority; 47 of the 53 studies, used SGA as a proxy for FGR. Gaccioli and 
colleagues, investigated whether an EFW below the 10th percentile in combinations 
with an elevated sFLIT1:PIGF ratio (at 36 weeks of gestation) was predictive for adverse 
pregnancy outcomes. They showed that this combination was strongly predictive 
for delivering a SGA infant (birth weight < 10th centile) plus perinatal morbidity and/
or preeclampsia 24. In a subsequent study, elevated FLIT1:PIGF ratio was combined 
with low abdominal circumference growth velocity (ACGV), and a composite 
measure generated by, the earlier mentioned, Delphi procedure 25, described as 
indicators of FGR 26. They found that at a gestational age of 28 as well as 36 weeks, 
the positive predictive value of ultrasonic screening for the delivery of a SGA infant 
with complications was doubled when it was combined with biochemical markers 
compared to the ultrasonic screening method alone. The relation with placental 
morphometry has not been examined in these studies.
CLINICAL RELEVANCE OF ANTENATAL AND POSTNATAL AS-
SESSMENT OF PLACENTAL MORPHOMETRY
In current clinical practice, placental morphometry is only routinely investigated 
and described at pathological examination, after delivery. In general, placentas are 
only routinely investigated in case of some adverse pregnancy outcomes. However, 
examination of placental morphometry, both in the antenatal and postnatal phase, 
can possibly disclose information for the detection of fetal growth restriction.
Antenatal assessment of placental morphometry
Evaluation of the placenta during pregnancy is usually only performed to assess the 
location of the placenta or to diagnose placental adhesion disorders (e.g., placenta 
praevia, placenta increta, placenta bilobata). Antenatal assessment of placental 
morphometry, alone or in relation to fetal size, is not routinely performed but may 
improve the identification of fetuses at risk for adverse outcomes caused by placental 
insufficiency. The theoretical advantage of antenatal assessment compared to 
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postnatal assessment of placental morphometry is obvious; relevant information from 
antenatal assessment does not only apply to the newborn or future pregnancies, but 
could also be of vital importance in the current pregnancy. It can allow the clinician to 
tailor monitoring- and intervention strategies to reduce the risk of adverse outcomes.
Unfortunately, literature regarding the clinical relevance of antenatal assessment 
of placental morphometry is still scarce. In this paragraph, we will summarize the 
existing literature on placental morphometry assessment during pregnancy with 
both ultrasound and MRI.
Figure 1. Schematic representation of the possible distribution of FGR within the total population 
consisting of SGA, AGA and LGA fetuses at a certain gestational age. Another gestational age-period 
or population will most likely have a different distribution. FGR, fetal growth restriction; SGA, small 
for gestational age; AGA, appropriate for gestational age; LGA, large for gestational age (reproduced 
with permission from 78).
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Antenatal assessment of placental morphometry with ultrasound
Measurements of placental diameter and thickness, using two-dimensional 
ultrasound, have been used as indicator of high-risk pregnancies and correlates 
with birth weight 27. Several studies have investigated these ultrasound measures 
in relation to SGA (birth weight < p10), and showed that placental diameter and 
thickness are lower in SGA fetuses 27–30. In addition, Schwartz and colleagues had 
the aim to combine early, direct ultrasound assessment of the placenta with other 
markers of placental development, such as mean of the uterine artery Doppler 
PI, to identify pregnancies delivering SGA infants 30. Placental volume, placental 
quotient (PQ= placental volume/gestational age), and mean placental diameter were 
significantly smaller in fetuses in the SGA group, compared to the AGA group. This 
indicates that a smaller placental mass is associated with SGA 31,32.
On the other hand, the placental morphology index (defined by mean placental 
diameter divided by placental quotient (PQ)) was significantly higher in the SGA group, 
demonstrating a closer association between slower fetal growth and a relatively wide 
and flat placenta, rather than a relatively thick placenta 30.
Studies that used FGR as outcome variable (Table 1) showed that abnormal placental 
shape (placental thickness > 4 cm or > 50% of placental length) were predictive for 
experiencing FGR 33–35. In addition, Proctor et al. showed that FGR was associated 
with small placental size (linear placental length <10cm), in a group of women with 
low first trimester PAPP-A (≤ 0.30 multiples of median) 36.
In order to assess placental morphometry during pregnancy with ultrasound, 
sonographic reliability of placental measurements has to be adequate. In this 
regard, a couple of limitations have to be addressed. First, there are no existing, 
in vivo, ultrasound reference charts of normal placental size. Although Higgins et 
al. described that the estimated placental biometry and volume during pregnancy 
are correlated with their measurements at postnatal assessment, they are not 
equal 37. In vivo measurements, performed within seven days before delivery, of 
placental length and width, and 3D placental volume measurements were smaller 
compared to ex vivo measurements 37. Placental depth and 2D placental volume 
measurements were found to be larger compared to their ex vivo correlates. These 
differences are probably caused by the collapse of intervillous space due to loss 
of maternal blood flow after birth and less stretching of the placenta due to the 
loss of intrauterine pressure from amniotic fluid and the baby volumes after birth. 
Azpurua et al. described that placental weight could be accurately predicted by 2D 
ultrasound with volumetric calculation 38. Second, intra- and inter-observer variability 
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play a much bigger role with in vivo sonographic measurements than ex vivo, real life 
measurements 37. Higgins et al. investigated the intra- and inter-observer variability 
between observations for placental measurements length, width, depth and volume 
performed by 2D ultrasound. The variability in measurements (intra- and inter-) was 
suboptimal with no intraclass correlation coefficient > 0.75 (Higgins et al., 2016). More 
recently, a new technique was established for estimating placental volume from 3D 
ultrasound scans through a semi-automated technique 39. In this study, placental 
volume of 2,393 pregnancies was assessed by three operators on the one hand, and 
this semi-automated tool on the other hand. The clinical utility of placental volume 
was tested by looking at prediction of SGA at term. Results showed good similarity 
between the operators and the tool, and almost identical clinical results for the 
prediction of SGA 39.
Antenatal assessment of placental morphometry with Magnetic Reso-
nance Imaging
Magnetic resonance imaging (MRI) is an established, safe method of imaging 
during second and third trimester of pregnancy, but currently mainly used for fetal 
imaging 40–42. The advantages of MRI compared to ultrasound, are the more accurate 
measurements of anatomical volume and the higher soft tissue contrast, and thus it 
has specific strengths in detecting abnormal placental morphometry. Furthermore, it 
has a larger field of view and, other than ultrasound, it is not dependent on its ability 
to penetrate tissue.
Reference values of placental volume by MRI measurements throughout gestation of 
healthy pregnancies, although in relatively small sample size, have been studied and 
are available now 43–45. Current research on placental imaging is much more focused 
on the more advanced techniques of functional MRI (fMRI), rather than assessment 
of placental morphometry with conventional MRI. These fMRI techniques, and their 
implications for diagnosing FGR, are not in the scope of this review but are described 
in the reviews of Avni et al. and Siauve et al. 46,47.
Although current research focuses more on the possibilities of fMRI, five studies 
specifically investigated the placental morphometry measurements with MRI in 
relation to FGR, or markers of FGR (Table 2). The study of Derwig et al. was the only 
one that used SGA as outcome rather than FGR, and showed that small placental 
volume is predictive for delivering a SGA-neonate, which is in line with the findings 
from other (ultrasound) studies and could be a physiological phenomenon 48. They 
also described that small placental volume was significantly associated with higher PI 
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of the uterine artery, a marker of FGR. Increased uterine artery PI is thought to reflect 
defective trophoblast invasion, which could result in reduced placental growth 49.
Three studies 50–52 investigated placental morphometry measurements in a FGR 
population compared to healthy controls. Although different definitions of FGR have 
been used (see Table 2), they all showed significantly reduced placental volume 
in the FGR population compared to the healthy pregnant population. Furthermore, 
Damodaram et al. showed that the placental volume remained significantly smaller 
throughout gestation in the FGR group, and that a lower placental volume was 
also associated with the severity of the FGR (detailed information on the severity 
subgroups can be found in Table 2) 50. Finally, Andescavage et al. described that 
the placental volume was significantly lower in a subgroup of the FGR-population 
with abnormal umbilical artery Doppler 52. Higher mean placental thickness, lower 
macroscopic placental surface area and increase in max placental thickness/
placental volume (PT/PV) ratio, were placental morphometry parameters that were 
significantly associated with FGR 50,51.
Further substantiation of the relevance of the max PT/PV ratio was shown by the 
significant correlation found between a higher max PT/PV ratio and the severity of 
the FGR, and the association with fetal and early neonatal morbidity in case of an 
increase of the max PT/PV ratio above the 95th percentile for gestation 50.
The last and most recent study of Dahdouh et al. had a slightly different study 
design. In this study placental morphometry, although in combination with placental 
textural features computed on 3D MRI images, were used in two machine learning 
frameworks to predict FGR and BW for both healthy and FGR fetuses 53. This semi-
automated framework was able to detect FGR-fetuses with a diagnostic accuracy 
of 86%, sensitivity of 86% and a specificity of 87%. In line with the other four studies, 
placental volume was one of the most important features for identification of FGR. 
Although this study had a small sample size (n=80), these results are promising, 
outperforming the current standard clinical tools for diagnosing FGR. Although MRI 
is increasingly used during pregnancy, especially at advanced gestation or in obese 
women 54, availability is limited and costs are high. Therefore, current clinical use of 
MRI in the assessment of placental morphometry is very limited.
Postnatal assessment of placental morphometry
After birth, standard placental measures are placental disk shape, diameter, surface 
area, disk thickness, weight, location of umbilical cord insertion site relative to the 
edge of the placental disk, and placental weight in relation to birth weight 55. It is 
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advised to use placental weight trimmed of extraplacental membranes and umbilical 
cord 55. Inconsistencies in preparation of the placenta before weighing remains in 
different studies. Therefore, it is important to check whether trimmed or untrimmed 
placental weights are used, as for direct comparisons between absolute placental 
weights, values should be standardized to trimmed placental weight 56.
There is increasing evidence that features of placental gross morphology are linked 
biologically to the functional capacity of the placenta 57, but it has received little 
clinical interest. The reason for this is the timing of investigation of the placenta: 
pregnancy conditions have either developed or not, and intra-uterine problems 
already have taken place before the possibility to investigate the placenta. However, 
postnatal morphology studies of the placenta give the opportunity to help in finding 
the neonate who suffered undetected growth restriction and should be monitored 
more closely during postnatal care. It is thus important to focus on the possible 
clinical relevance of placental morphometry in retrospectively diagnosing impaired 
growth.
Postnatal placental morphometry in relation to ultrasound markers of fetal 
growth restriction
It has been shown that utero-placental blood flow and fetal growth can be related 
to the gross morphometry of the placenta 58. Small placental area and low placental 
weight were associated with, respectively, higher uterine and higher umbilical artery 
PI. Both placental area and weight were associated with a slower fetal ACGV 58. The 
circularity of the placenta was associated with the uterine artery, but not the umbilical 
artery, flow velocity waveform. These results show that size and shape of the placenta 
are depending on the vascular function of the placenta from both the maternal 
and fetal side. Although some studies have focused on the relationship between 
ultrasound measurements (e.g., fetal biometry, Doppler flow velocity waveforms) and 
adverse pregnancy outcome 21,59, more literature on the relationship with postnatal 
placental morphometry is lacking.
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Birth weight to placenta weight-ratio in relation to ultrasound markers
Research showed that not only the size and weight of the placenta, but also the 
weight of the placenta in relation to birth weight was associated with both umbilical 
and uterine artery PI 60. Specifically, high BWPW-ratio was associated with both higher 
umbilical artery PI (26 weeks of gestation) and higher uterine artery PI (20 weeks of 
gestation), two markers of decreased placental function. Low BWPW-ratio was not 
associated with either umbilical or uterine artery PI, however it was with maternal 
and neonatal morbidity 60. Decreased placental function may sound contradictory, 
since placentas in the group of high BWPW-ratio can also be seen as very efficient. 
It might be plausible that the relatively small placentas in the group of high BWPW-
ratio work at their maximum function capability for that volume, and that the birth 
weight actually could have been higher with higher placental volume. With this said, 
we would expect high BWPW-ratio to be related to adverse postnatal outcome 
related to starvation caused by too relatively small placentas, which was not shown 
by recent research 60. This might be the result of intervention bias: those cases with 
high umbilical and uterine artery PI might have experienced an earlier induction of 
labor, resulting in lower neonatal morbidity 61. Another explanation might be the role 
of placental surface area. Those placentas in the group of low BWPW-ratio might 
be thicker but have a small macroscopic placental surface area, resulting in a less 
efficient exchange process of oxygen, nutrients, and fetal waste products. In the 
group of high BWPW-ratio the reverse might be true; within this group the placentas 
might have a large macroscopic placental surface area, but are really thin, explaining 
the lower placental weight.
Postnatal placental morphometry in relation to birth weight and fetal 
growth restriction
Various studies have looked at the relationship between postnatal placental 
morphometry and birth weight. These studies showed that low birth weight was 
associated with lower placental weight and volume, and a smaller placental area 
62,63. Balihallimath et al. studied the relationship of placental morphometry more 
specifically in different birth weight groups, classified by gender 63. In the groups with 
birth weight less than 3,000 grams, the surface area of the placenta was smaller in 
male babies compared to female babies. When birth weight exceeded 3,000 grams, 
the surface area was larger in male babies 63. In addition, it has been described that 
male babies have a higher birth weight compared to female babies, but have the 
same placental weight (increased BWPW-ratio) 64,65. Male babies also have a higher 
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perinatal mortality 66, rather than more efficient they may also be just the fetus that 
runs the risk of increased mortality to maximize growth. We think the placenta has a 
functional reserve to cope with extra demands, which explains why many stillbirths 
have pre-existing injury 12.
Although a small placenta suggests reduced reserve, the association between low 
birth weight and low placental weight and size, could potentially be physiological 
(small baby, small placenta) therefore statements regarding the association between 
placental morphometry and pathological, low or high, birth weight, require an 
investigation of proportionality, of the relationship of placental morphometry with 
BWPW-ratio. Also the site of the umbilical cord insertion has been linked to birth 
weight 67–69. Kowsalya et al. indicated that the cord insertion was more often eccentric 
or marginal in the group of infants with low birth weight 62. Yampolsky et al. pointed 
out that this central insertion influences placental efficiency positively 67. Conflicting 
results were published by Haeussner et al. who reported that the location of the 
cord insertion in relation to the edge of the placental disk did not correlate with birth 
weight, and eccentric cord insertion did not necessarily compromise efficiency of the 
normal human placenta 68. Furthermore, they reported that parameters regarding the 
form of the placenta (e.g., diameter, thickness, roundness, eccentricity of the cord 
insertion) correlate with both birth weight and placental weight 68.
It has been proposed that FGR and morphologic changes of the placenta, are caused 
by impaired placental perfusion, due to reduced placental vascular bed in chronic 
fetal hypoxia, which causes oxidative stress of the fetal vasculature 70,71. Junaid et 
al. investigated micro and macrovasculature of placentas from normal and FGR 
pregnancies, and observed hyposvascularity in the peripheral lobules of placentas 
from FGR pregnancies 72. Another aspect that may result in altered morphometry, is 
the fact that FGR related hypoxia influences angiogenesis via various growth factor 
receptors 73. Three studies were found that investigated the relationship between 
postnatal placental morphometry and FGR 74–76 (Table 3).
These three studies classified FGR based on deficient fetal growth on ultrasound 
scans and EFW less than 10th centile. They found that FGR was associated with 
changes in placental morphometry such as decreased surface areas, decreased 
placental diameter, and decreased placental volume and placental weight 74–76.
FUTURE PERSPECTIVES
As described, various studies have focused on the relationship between placental 
morphometry and fetal growth and birth weight. Unfortunately, only limited research 
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has been performed focusing on associations between placental morphometry 
and FGR. The often seen “SGA-FGR confusion” in FGR studies will lead to weaker 
associations with any effective screening test, including placental morphometry 
imaging. Although cheap and easy to obtain, the postnatal placenta will only aid 
the diagnosis of FGR in retrospect. This could result in altered management by less 
monitoring in healthy SGA and more monitoring in FGR, regardless of birth weight. 
Although we expect that aspects of placental morphometry can play a role in the 
diagnostic process of FGR, mainly postnatally, additional components, as part of 
a multiparameter model, might need to be taken into account with the aspects of 
placental morphometry. A small placenta, or abnormally flat or thick placenta may 
prompt review for assessment of the baby and the histology of the placenta to see 
if other findings to suggest maternal malperfusion or other pathology is present.
Further use of placental morphometry in the diagnostic process of FGR can be 
explored by for example BWPW-ratio in relation to abdominal circumference growth 
velocity (ACGV), macroscopic placental surface area (and placental volume) and 
placenta serum biomarkers. As suggested in a recent paper about screening for fetal 
growth restriction 77, it is expected that future screening tests for FGR will include 
several measurements, which are obtained from both imaging procedures and 
measurements of biomarkers. For the development of such a model it is essential 
that every single parameter is measured and scaled in the association with FGR, in 
order to generate consistent associations. Regarding imaging procedures, research 
has shown that placental imaging through MRI might be of clinical use in predicting 
FGR. Nowadays, MRI is already in use for fetal imaging, so possibly placental imaging 
can be used in the near future.
CONCLUSIONS
It is of great importance that clinically useful, and easy to perform, methods will be 
generated in order to improve the antenatal and postnatal screening for, and diagnosis 
of, fetuses with FGR who have increased risk on adverse pregnancy outcomes. In 
this literature review we intended to give an overview on the clinical relevance of 
placental morphometry in the detection of FGR. In current clinical practice, antenatal 
placental imaging is difficult, and the placenta is not routinely examined after birth, 
nor in a standardized way, despite the possible value in several parameters of 
impaired growth of the fetus. Future research can focus on the relationship between 
placental morphometry, FGR and its complications, to improve screening for FGR, and 
to determine the biological pathways that can be linked to placental dysfunction, in a 
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group of optimally phenotyped cases of FGR. With this, placental morphometry might 
be implemented in clinical practice, possibly as part of a multiparameter model.
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